Neo Ivy Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Neo Ivy Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,474	Closed	-$409K	–	693
2021 Q2	$409K	Buy	+2,474	New	+$413K	0.41%	85
2020 Q2	–	Sell	-1,022	Closed	-$85K	–	647
2020 Q1	$85K	Buy	+1,022	New	+$99.7K	0.14%	241
2019 Q1	–	Sell	-6,769	Closed	-$622K	–	425
2018 Q4	$622K	Buy	+6,769	New	+$685K	0.49%	80

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Neo Ivy Capital Management's PRAH Position: Q3 2021 in Review

Neo Ivy Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,474 shares — an estimated $409K sold.

Neo Ivy Capital Management first reported a position in PRAH in Q4 2018 and held it in 3 quarters. The position peaked at $622K in Q4 2018. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Neo Ivy Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Neo Ivy Capital Management sold 2,474 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $409K.
Neo Ivy Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 3 quarters.
Neo Ivy Capital Management's PRA Health Sciences, Inc. position peaked at $622K in Q4 2018.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Neo Ivy Capital Management's 13F filing for Q3 2021, filed 16 Nov 2021.